About PHARMASEAL
PHARMASEAL is a company based in Nottingham (United Kingdom) founded in 2016 by Daljit Cheema.. PHARMASEAL has raised $2.67 million across 3 funding rounds from investors including Mercia and Midlands Engine Investment Fund. The company has 8 employees as of March 31, 2022. PHARMASEAL offers products and services including Engility® CTMS, Engility® eTMF, and Engility® Connect. PHARMASEAL operates in a competitive market with competitors including Advarra, Leucine, Datapharm, Flinn and Health Language, among others.
- Headquarter Nottingham, United Kingdom
- Employees 8 as on 31 Mar, 2022
- Founders Daljit Cheema
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Pharmaseal International Limited
- Date of Incorporation 08 Feb, 2016
- Jurisdiction NOTTINGHAM, NOTTINGHAMSHIRE, ENGLAND
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$2.67 M (USD)
in 3 rounds
-
Latest Funding Round
$673.14 K (USD), Seed
Sep 07, 2020
-
Investors
Mercia
& 1 more
-
Employee Count
8
as on Mar 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of PHARMASEAL
PHARMASEAL offers a comprehensive portfolio of products and services, including Engility® CTMS, Engility® eTMF, and Engility® Connect. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Software for overseeing and executing clinical trials efficiently.
Platform for electronic trial master file handling and storage.
Tool for supply chain collaboration in clinical research processes.
Unlock access to complete
Funding Insights of PHARMASEAL
PHARMASEAL has successfully raised a total of $2.67M across 3 strategic funding rounds. The most recent funding activity was a Seed round of $673.14 thousand completed in September 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Seed — $673,143
-
First Round
First Round
(23 Jan 2018)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2020 | Amount | Seed - PHARMASEAL | Valuation |
investors |
|
| May, 2019 | Amount | Seed - PHARMASEAL | Valuation | Midlands Engine Investment Fund |
|
| Jan, 2018 | Amount | Seed - PHARMASEAL | Valuation | Mercia |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in PHARMASEAL
PHARMASEAL has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Mercia and Midlands Engine Investment Fund. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment funding is provided to support Midlands SMEs growth.
|
Founded Year | Domain | Location | |
|
Investment management services are provided by Mercia to various clients.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by PHARMASEAL
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - PHARMASEAL
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Pharmaseal Comparisons
Competitors of PHARMASEAL
PHARMASEAL operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Advarra, Leucine, Datapharm, Flinn and Health Language, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Global research compliance services including IRB and consulting are provided.
|
|
| domain | founded_year | HQ Location |
Developer of AI-powered software for pharmaceutical manufacturing, quality, and laboratory
|
|
| domain | founded_year | HQ Location |
Regulatory compliance software for pharma and healthcare professionals is provided.
|
|
| domain | founded_year | HQ Location |
Compliance processes are automated for medical device manufacturers using AI.
|
|
| domain | founded_year | HQ Location |
Enterprise terminology management for medical coding is offered.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Pharmaseal
Frequently Asked Questions about PHARMASEAL
When was PHARMASEAL founded?
PHARMASEAL was founded in 2016 and raised its 1st funding round 2 years after it was founded.
Where is PHARMASEAL located?
PHARMASEAL is headquartered in Nottingham, United Kingdom.
Who is the current CEO of PHARMASEAL?
Daljit Cheema is the current CEO of PHARMASEAL. They have also founded this company.
Is PHARMASEAL a funded company?
PHARMASEAL is a funded company, having raised a total of $2.67M across 3 funding rounds to date. The company's 1st funding round was a Seed of $695.8K, raised on Jan 23, 2018.
How many employees does PHARMASEAL have?
As of Mar 31, 2022, the latest employee count at PHARMASEAL is 8.
What does PHARMASEAL do?
PHARMASEAL was founded in 2016 in Nottingham, United Kingdom, as a SaaS-based B2B platform focused on clinical trial governance for biopharmaceutical companies. A cloud-based system is provided to manage and monitor trials in compliance with good clinical practice standards. The product Engility supports study and task management. Modules for patient safety and license-regulatory tools are planned for development. Operations center on regulatory adherence in the biopharma sector.
Who are the top competitors of PHARMASEAL?
What products or services does PHARMASEAL offer?
PHARMASEAL offers Engility® CTMS, Engility® eTMF, and Engility® Connect.
Who are PHARMASEAL's investors?
PHARMASEAL has 2 investors. Key investors include Mercia, and Midlands Engine Investment Fund.